Literature DB >> 10994328

[Central serous chorioretinopathy and psychological stress].

R Conrad1, I Bodeewes, G Schilling, F Geiser, K Imbierowicz, R Liedtke.   

Abstract

BACKGROUND: To date we know little about the etiology of central serous chorioretinopathy. Former investigations discussed inadequate coping strategies and critical life-events as important psychological aspects. In this study we investigated the relationship between central serous chorioretinopathy and stress.
MATERIALS AND METHODS: 35 male patients with central serous chorioretinopathy (group 1) were compared to 21 male patients with traumatic eye diseases. The evaluated data included sociodemographic data as well as data regarding the patients coping strategies, critical live-events before outbreak of the disease, personality factors and general physical complaints.
RESULTS: Group 1 showed a significantly higher amount of general physical complaints, measured with a complaints questionnaire (B-L). In a personality inventory (FPI-R) it scored significantly higher on the scales emotional instability and strain, significantly lower on the scale extraversion.
CONCLUSION: The results indicate that patients with central serous chorioretinopathy are more stressed because of inadequate coping strategies, which can be seen in a higher amount of physical complaints.

Entities:  

Mesh:

Year:  2000        PMID: 10994328     DOI: 10.1007/s003470070059

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  13 in total

1.  [Central serous chorioretinopathy (CSC)].

Authors:  H Baraki; N Feltgen; J Roider; H Hoerauf; C Klatt
Journal:  Ophthalmologe       Date:  2010-05       Impact factor: 1.059

2.  [Spectral domain OCT in central serous chorioretinopathy: description of retinal changes].

Authors:  V Valet; C P Lohmann; M Maier
Journal:  Ophthalmologe       Date:  2012-09       Impact factor: 1.059

3.  [Selective retina therapy in central serous chorioretinopathy with detachment of the pigmentary epithelium].

Authors:  C Klatt; H Elsner; E Pörksen; R Brinkmann; A Bunse; R Birngruber; J Roider
Journal:  Ophthalmologe       Date:  2006-10       Impact factor: 1.059

4.  Association of a Haplotype in the NR3C2 Gene, Encoding the Mineralocorticoid Receptor, With Chronic Central Serous Chorioretinopathy.

Authors:  Elon H C van Dijk; Rosa L Schellevis; Maaike G J M van Bergen; Myrte B Breukink; Lebriz Altay; Paula Scholz; Sascha Fauser; Onno C Meijer; Carel B Hoyng; Anneke I den Hollander; Camiel J F Boon; Eiko K de Jong
Journal:  JAMA Ophthalmol       Date:  2017-05-01       Impact factor: 7.389

5.  QT interval dispersion in the patients with central serous chorioretinopathy.

Authors:  Necati Dagli; Burak Turgut; Rumeysa Tanyildizi; Sabiha Kobat; Mehmet Ali Kobat; Orhan Dogdu
Journal:  Int J Ophthalmol       Date:  2015-02-18       Impact factor: 1.779

6.  [Therapy options for chronic central serous chorioretinopathy. Photodynamic therapy combined with bevacizumab - a case series].

Authors:  M Maier; V Valet; N Feucht; C P Lohmann
Journal:  Ophthalmologe       Date:  2011-11       Impact factor: 1.059

7.  Psychosomatic aspects in patients with central serous chorioretinopathy.

Authors:  C Spahn; J Wiek; T Burger; L Hansen
Journal:  Br J Ophthalmol       Date:  2003-06       Impact factor: 4.638

8.  Epidemiology of idiopathic central serous chorioretinopathy in Taiwan, 2001-2006: a population-based study.

Authors:  Der-Chong Tsai; Shih-Jen Chen; Chin-Chou Huang; Pesus Chou; Chia-Min Chung; Po-Hsun Huang; Shing-Jong Lin; Jaw-Wen Chen; Tseng-Ji Chen; Hsin-Bang Leu; Wan-Leong Chan
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

9.  Temperament and character personality profile and illness-related stress in central serous chorioretinopathy.

Authors:  Rupert Conrad; Franziska Geiser; Alexandra Kleiman; Berndt Zur; Andrea Karpawitz-Godt
Journal:  ScientificWorldJournal       Date:  2014-02-16

10.  Cushing's Syndrome and Hypothalamic-Pituitary-Adrenal Axis Hyperactivity in Chronic Central Serous Chorioretinopathy.

Authors:  Femke M van Haalen; Elon H C van Dijk; Olaf M Dekkers; Maurice B Bizino; Greet Dijkman; Nienke R Biermasz; Camiel J F Boon; Alberto M Pereira
Journal:  Front Endocrinol (Lausanne)       Date:  2018-02-20       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.